« Merck Joins Novo to Reassure FDA of Diabetes Drug Safety | Main | FDA probes deaths of two patients on Lilly schizophrenia drug »

June 13, 2013

Drugmakers to cooperate in safety review of diabetes drugs

Quoted from http://www.reuters.com/article/2013/06/12/us-diabetes-safety-idUSBRE95B17J20130612

Drugmakers to cooperate in safety review of diabetes drugs

By Bill Berkrot

NEW YORK | Wed Jun 12, 2013 5:14pm EDT

NEW YORK (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between widely used diabetes medicines and pancreatic cancer and other safety problems.

The American Diabetes Association (ADA) this week called for a new evaluation of clinical data on drugs used to control blood sugar for patients with type 2 diabetes. They include Merck & Co's $4 billion a year Januvia franchise, Novo Nordisk's Victoza, and Byetta and Onglyza from Bristol-Myers Squibb Co and AstraZeneca Plc, among others.

"People who are taking these medications, or who may consider taking them, should have the benefit of all that is currently known about their risks and advantages in order to make the best possible decisions about their treatment," Dr. Robert Ratner, ADA's chief scientific and medical officer, said in a statement.

[Article continues at original source]

Related articles
Cancer of The Pancreas: Possible Side Effect For Diabetics Who Use Byetta, Januvia, Or Victoza?

Posted at 09:31 AM in Byetta, Januvia, Onglyza, Victoza |

Tags: AstraZeneca Plc, Bristol-Myers Squibb Co, Byetta, drug injury, FDA, Januvia, Merck & Co, Novo Nordisk, Onglyza, pancreatic cancer, side effects, Victoza

Comments

Search Engine

  • Google

    WWW
    www.drug-injury.com

Patient Advisory

  • The prescription drugs discussed on this site are approved for use by the the Food and Drug Administration (FDA). Patients should not stop taking any prescription drug without seeking the advice of their medical doctor. This site is not affiliated with any of the drug companies or the FDA.

Quick Contact Form

  • In a rush? You can use our Quick Contact Form to tell us the basic facts about your case.

Free Case Evaluation


  • We encourage you to submit a Drug Injury Legal Case Evaluation – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible drug injury case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience handling drug injury lawsuits.

Drug Injury Watch

Thank You For Reading


Subscribe to Lamb Law Office Newsletter

Subscribe to our Lamb Law Office Newsletter for periodic updates about some of the cases we are working on for clients. We include, also, an information resource you might find helpful in each Newsletter.

* indicates required